Mediators of Inflammation (Jan 1995)

Nitric oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats

  • M. R. Pierce,
  • C. A. Voelker,
  • I. R. S. Sosenko,
  • S. Bustamante,
  • S. M. Olister,
  • X.-J. Zhang,
  • D. A. Clark,
  • M. J. S. Miller

DOI
https://doi.org/10.1155/S096293519500069X
Journal volume & issue
Vol. 4, no. 6
pp. 431 – 436

Abstract

Read online

We evaluated the effects of sustained perinatal inhibition of NO synthase (NOS) on hyperoxia induced lung injury in newborn rats. NG-nitro-Larginine-methyl-ester (L-NAME) or untreated water was administered to pregnant rats for the final 7 days of gestation and during lactation; followed by postnatal exposure to hyperoxia (>95% O2) or room air. The survival rate of L-NAME treated pups when placed in > 95% O2 at birth was significantly lower than controls from day 4 (L-NAME, 87%; control pups, 100%, p < 0.05) to 14 (L-NAME, 0%; control pups, 53%, p < 0.05). Foetal pulmonary artery vasoconstriction was induced by L-NAME with a decrease in internal diameter from 0.88 ± 0.03 mm to 0.64 ± 0.01 mm in control vs. L-NAME groups (p < 0.05), respectively. We conclude that perinatal NOS inhibition results in pulmonary artery vasoconstriction and a decreased tolerance to hyperoxia induced lung injury in newborn rats.